articleThe Journal of Experimental MedicineMay 9, 2011BRONZE OA

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

Regulus Therapeutics (United States) · California Institute of Technology · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Excessive or inappropriate activation of the immune system can be deleterious to the organism, warranting multiple molecular mechanisms to control and properly terminate immune responses. MicroRNAs (miRNAs), ∼22-nt-long noncoding RNAs, have recently emerged as key posttranscriptional regulators, controlling diverse biological processes, including responses to non-self. In this study, we examine the biological role of miR-146a using genetically engineered mice and show that targeted deletion of this gene, whose expression is strongly up-regulated after immune cell maturation and/or activation, results in several immune defects. Collectively, our findings suggest that miR-146a plays a key role as a molecular…

No related works found for this paper.

Funding